Wesfarmers (ASX: WES) has completed the first phase review of its iconic Target brand, confirming that its financial viability is not sustainable and that the majority of stores will be transformed into Kmart stores which better reflects the retail needs of Australian customers. The decision comes as Target has continued to see declining sales with
Read More
Amidst the trade tensions around Australian barley, farmer Hugh Honey has returned fire to China threatening to withhold affection towards their women until the 80% tariffs on his barley exports are lifted. Having failed in three attempts to feature on reality TV show The Farmer Wants a Wife, Honey has since turned to Tinder and
Read More
In a proactive move to up their defence in the fight against neo-terrorism and disruption, the European Union Police underwent a tender process for drone defence solutions with DroneShield (ASX: DRO) coming out on top to supply EU police forces with their DroneGun Tactical™ solution. The framework agreement will see DroneShield supply DroneGun Tactical™ to
Read More
Make no mistake: the sun has set on the golden era of travel, with both leisure and business passengers likely to avoid the airline lounges and cruise ship terminals for months to come. In hindsight, the sector’s woes were brewing even before the Wuhan pestilence was heard of, with the British-based packaged holiday veteran Thomas
Read More
Biotech company Imagion Biosystems (ASX: IBX) has secured a major boost in resources having secured Siemens Healthineers (FWB: SHL) as a collaboration partner for their proprietary cancer detecting agent. The collaboration will centre around Imagion’s MagSense™ nanoparticles which are designed to be visible on a MRI scan once they attach to cancer cells. MagSense™ has
Read More
As part of their plans to collaborate with the NRL on concussion solutions, Impression Healthcare (ASX: IHL) has appointed NRL star James Graham to its advisory board to assist with the development of their medicinal cannabis products. In particular, Graham will offer advice on ‘real world’ aspects of the clinical program for IHL-216A, a cannabinoid
Read More
